SKY CHANCE TECHNOLOGY LIMITED
Company number 13658062 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
SKY CHANCE TECHNOLOGY LIMITED - Analysis Report
Company Number: 13658062
Analysis Date: 2025-07-20 19:14 UTC
Financial Health Assessment - SKY CHANCE TECHNOLOGY LIMITED
1. Financial Health Score: D
Explanation:
SKY CHANCE TECHNOLOGY LIMITED shows persistent negative net assets and working capital deficits over multiple years, indicating financial distress. The company’s liabilities significantly exceed its current assets, reflecting poor liquidity and solvency. While still active, these symptoms suggest a precarious financial condition that requires urgent attention.
2. Key Vital Signs (Core Financial Metrics):
| Metric | 2024 Value (£) | Interpretation |
|---|---|---|
| Current Assets | 721 | Extremely low cash and receivables; insufficient buffer |
| Current Liabilities | 14,192 | Short-term debts are substantial relative to assets |
| Net Current Assets | -13,471 | Negative working capital indicates liquidity problems |
| Net Assets (Shareholders’ Funds) | -13,471 | Company is insolvent on a balance sheet basis |
| Employee Count | 3 | Small workforce consistent with micro-entity status |
| Account Category | Micro | Minimal filing requirements but limited financial scope |
Interpretation of Vital Signs:
- Healthy cash flow would show positive net current assets, allowing the company to meet short-term obligations comfortably. Here, the negative net current assets are a symptom of distress, suggesting potential cash flow issues.
- The negative net assets indicate the company owes more than it owns, a critical warning signal akin to a patient showing signs of organ stress.
- The steady deterioration from previous years (-8,854 in 2022 to -13,471 in 2024) indicates worsening balance sheet health.
3. Diagnosis: Financial Condition Assessment
SKY CHANCE TECHNOLOGY LIMITED is currently in a state of financial distress, exhibiting the following symptoms:
- Liquidity Strain: Negative working capital implies the company may struggle to pay its bills on time, risking supplier confidence and operational disruption.
- Insolvency Risk: Negative shareholders’ funds indicate liabilities exceed assets, which if persistent, may lead to insolvency proceedings if not addressed.
- No Audit Requirement: As a micro-entity, the company avoids audit, which limits external assurance on financial health but also reduces compliance costs.
- Small Scale Operations: With only three employees and micro-entity status, the company’s scale may limit its ability to generate rapid financial improvement without new capital or operational changes.
- Stable Ownership: Two directors each controlling 25-50% shares suggests clear ownership; however, no indication of fresh capital injections or restructuring in recent filings.
Overall, the company is like a patient with chronic but manageable symptoms who needs urgent intervention to avoid further deterioration.
4. Recommendations: Specific Actions to Improve Financial Wellness
Liquidity Improvement:
- Seek short-term financing or capital injection to improve cash reserves.
- Negotiate longer payment terms with creditors to ease immediate cash demands.
- Accelerate receivables collection or convert non-essential assets to cash.
Cost Control & Operational Efficiency:
- Review operating expenses and reduce discretionary spending.
- Consider restructuring workforce or outsourcing to reduce fixed costs.
Strategic Business Review:
- Explore new revenue streams, partnerships, or markets to increase turnover.
- Leverage core competencies in IT services (data processing, software development) to win new contracts.
Financial Monitoring:
- Implement rigorous cash flow forecasting to anticipate liquidity crunches.
- Prepare contingency plans for worst-case scenarios such as insolvency risks.
Professional Advice:
- Engage with financial advisors or insolvency practitioners early to explore turnaround options.
- Consider whether the company structure or business model needs revision to sustain long-term health.
Medical Analogy Summary:
The company presents with symptoms of financial distress akin to a patient with inadequate blood flow (cash) and weakened organs (net assets). Without intervention—the equivalent of medical treatment—there is a risk of systemic failure (insolvency). However, with prompt corrective action, there is a potential for recovery and return to financial health.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.